Cover Image
市場調查報告書

止血劑市場預測:凝血酶·氧化再生纖維素系·複合止血劑·明膠系·膠原蛋白系·纖維蛋白膠

Hemostatic Agents Market: By Type (Thrombin, Oxidized Regenerated Cellulose, Combination, Gelatin, Collagen, Fibrin Sealants); By Treatment (Cardiovascular, General, Digestive, Neurological); By End User & Geography - Forecast (2016-2022)

出版商 IndustryARC 商品編碼 622673
出版日期 內容資訊 英文 171 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
止血劑市場預測:凝血酶·氧化再生纖維素系·複合止血劑·明膠系·膠原蛋白系·纖維蛋白膠 Hemostatic Agents Market: By Type (Thrombin, Oxidized Regenerated Cellulose, Combination, Gelatin, Collagen, Fibrin Sealants); By Treatment (Cardiovascular, General, Digestive, Neurological); By End User & Geography - Forecast (2016-2022)
出版日期: 2017年05月05日 內容資訊: 英文 171 Pages
簡介

本報告提供全球止血劑的市場調查,彙整市場定義和概要,競爭環境與市場佔有率,產品基準,市場的各種影響因素及市場機會分析,價值鏈,市場生命週期,類型·治療區分·終端用戶·地區/各主要國家趨勢與市場規模的變化與預測,主要企業簡介等資訊。

第1章 市場概要

第2章 摘要整理

第3章 市場環境

  • 市場佔有率分析
  • 財務分析
  • 終端用戶的分析
  • 產品基準
  • 專利分析

第4章 市場影響因素

  • 成長推進因素
  • 阻礙成長要素·課題
  • 市場魅力

第5章 策略性市場分析

  • 價值鏈分析
  • 市場機會分析
  • 產品生命週期
  • 價格分析

第6章 止血劑市場分析·預測:各類型

  • 簡介
  • 凝血酶
  • 明膠系
  • 膠原蛋白系
  • 氧化再生纖維素系
  • 複合止血劑
  • 纖維蛋白膠
  • 其他

第7章 止血劑市場分析·預測:治療類別

  • 簡介
  • 心臟血管
  • 一般外科
  • 消化器官外科
  • 神經外科
  • 其他

第8章 止血劑市場分析·預測:各終端用戶

  • 簡介
  • 醫院
  • 外科中心
  • 看護設施
  • 其他

第9章 止血劑市場分析·預測:各地區

  • 簡介
  • 南北美洲
    • 美國
    • 加拿大
    • 墨西哥
    • 巴西
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲 & 紐西蘭
    • 韓國
    • 其他
  • 其他
    • 非洲
    • 中東

第10章 市場熵

第11章 企業簡介

  • Baxter International Incorporation
  • C.R. Bard Incorporation
  • B.Braun Melsungen AG
  • Integra Life Sciences Corporation
  • Equimedical
  • Marine Polymer Technologies
  • Gelita GmbH
  • Johnson and Johnson Services Inc
  • Pfizer Inc
  • Advanced Medical Solutions Group
  • Vascular Solutions, Inc
  • Z-Medica LLC
  • Mallinckrodt Plc

第12章 附錄

目錄

Hemostats are instruments used to reduce or halt bleeding during a surgery. These can be enabled by the use of smearing pressure, stitching the bleeding or using thermal energy devices. Hemostats generally are used to clot the blood during surgical procedures. Technical advancements have increased the usage of topical hemostatic agents in an extensive variety of surgical situations. Make it into a different sentence. New tissue sealants and hemostats in the market have addressed issue related to tissue contamination with previous sealants. How the new tissue sealants are addressing the previous sealant. New tissue sealants helps in reducing tissue contamination. Global hemostatic agents market is estimated to grow at a CAGR of 7.1% to reach $8,347.9m by 2022.

The report analyzes the hemostatic agents market by type, by treatment and by end user. The market by types covered in the report are thrombin, gelatin, collagen, oxidized regenerated, fibrin sealants and combination hemostats. Fibrin Sealants are estimated to be the fastest growing hemostatic agents during the forecast period 2017-2022. The hemostatic agents market is also segmented by treatment which includes cardio vascular, general surgery, digestive and neuro-surgery. This report highlights the end users of hemostatic agents such as hospitals, surgery centers and nursing homes. The report estimates the size of the global market in value terms ($million).

Hemostatic Agents Market

The report provides market size and forecast for APAC, Europe, Americas and RoW. A detailed qualitative analysis of the factors responsible to driving and restraining growth of the hemostatic agents market and future opportunities are provided in the report. The report profiles thirteen key players of the hemostatic agents market.

Sample Cited Companies Profiled in this Report are:

Johnson & Johnson Services, Inc. (U.S.)

Baxter International Incorporation (U.S.)

C.R. Bard Incorporation (U.S.)

B.Braun Melsungen AG (Germany)

Advanced Medical Solutions Group (U.K.)

30+.

1. Hemostatic Agents Market Overview

2. Hemostatic Agents Market Executive Summary

3. Hemostatic Agents Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Financial Analysis
  • 3.3. End User Profiling
  • 3.4. Product Benchmarking
  • 3.5. Patent Analysis

4. Hemostatic Agents Market Forces

  • 4.1. Market Drivers
  • 4.2. Market Constraints & Challenges
  • 4.3. Attractiveness of Hemostatic Agents Market
    • 4.3.1. Power of Suppliers
    • 4.3.2. Power of Buyers
    • 4.3.3. Threat of Substitutes
    • 4.3.4. Threat of New entrants
    • 4.3.5. Degree of Competitive Rivalry

5. Hemostatic Agents Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Opportunities Analysis
  • 5.3. Market Life Cycle Analysis
  • 5.4. Pricing Analysis

6. Hemostatic Agents Market - By Type

  • 6.1. Introduction
  • 6.2. Thrombin Based Hemostats
  • 6.3. Gelatin Based Hemostats
  • 6.4. Collagen Based Hemostats
  • 6.5. Oxidized Regenerated Cellulose Based Hemostats
  • 6.6. Combination Hemostats
  • 6.7. Fibrin Sealants
  • 6.8. Others

7. Hemostatic Agents Market - By Treatment

  • 7.1. Introduction
  • 7.2. Cardiovascular
  • 7.3. General Surgery
  • 7.4. Digestive Surgery
  • 7.5. Neurosurgery
  • 7.6. Others

8. Hemostatic Agents Market - By End User

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Surgery Centers
  • 8.4. Nursing Homes
  • 8.5. Others

9. Hemostatic Agents Market -Geographic Analysis

  • 9.1. Introduction
  • 9.2. Americas
    • 9.2.1. U.S
    • 9.2.2. Canada
    • 9.2.3. Mexico
    • 9.2.4. Brazil
    • 9.2.5. Rest of Americas
  • 9.3. Europe
    • 9.3.1. U.K.
    • 9.3.2. Germany
    • 9.3.3. France
    • 9.3.4. Italy
    • 9.3.5. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. India
    • 9.4.4. Australia & New Zealand
    • 9.4.5. South Korea
    • 9.4.6. Rest of APAC
  • 9.5. RoW
    • 9.5.1. Africa
    • 9.5.2. Middle East

10. Hemostatic Agents Market Entropy

11. Hemostatic Agents Market Company Profiles

  • 11.1. Baxter International Incorporation (U.S.)
  • 11.2. C.R. Bard Incorporation (U.S.)
  • 11.3. B.Braun Melsungen AG (Germany)
  • 11.4. Integra Life Sciences Corporation (U.S.)
  • 11.5. Equimedical (Netherlands)
  • 11.6. Marine Polymer Technologies (U.S.)
  • 11.7. Gelita GmbH (Germany)
  • 11.8. Johnson and Johnson Services Inc (U.S.)
  • 11.9. Pfizer Inc (U.S.)
  • 11.10. Advanced Medical Solutions Group (U.K.)
  • 11.11. Vascular Solutions, Inc (U.S.)
  • 11.12. Z-Medica LLC (U.S.)
  • 11.13. Mallinckrodt Plc (U.S.)

More than 30 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

12. Appendix

  • 12.1. Abbreviations
  • 12.2. Sources
  • 12.3. Research Methodology
  • 12.4. Bibliography
  • 12.5. Compilation of Expert Insights
  • 12.6. Disclaimer
Back to Top